Combining EVP roles of Human Health Biosolutions and Strategy & Integration

As a next step on Novonesis' integration journey, we combine the two EVP areas Human Health Biosolutions and Strategy & Integration. Amy Byrick will open a new chapter in her life and pursue a non-Executive career. She will therefore step down from her position as Executive Vice President of Human Health Biosolutions and leave the company by July 31. Amy joined Novozymes' Executive Leadership Team in 2021 as EVP of Strategy & Transformation, and she was appointed Executive Vice President of Human Health Bio ...